查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2040858

覆膜支架市場規模、佔有率和趨勢分析報告：按器材類型、解剖部位、地區和細分市場預測（2026-2033 年）

Covered Stent Market Size, Share & Trends Analysis Report By Device Type (Balloon-Expandable Covered Stent, Self-Expanding Covered Stent), By Anatomy, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

覆蓋支架市場概述

全球覆膜支架市場預計到 2025 年將達到 14 億美元，預計到 2033 年將達到 21 億美元，2026 年至 2033 年的複合年成長率為 4.6%。

這一成長是由周邊動脈疾病和複雜主動脈髂動脈閉塞的日益普遍、血管內治療的增加以及對微創血運重組的日益偏好所推動的。

覆膜支架設計的進步，包括輸送性能的提升、徑向支撐力的增強以及長期通暢性的提高，持續推動其在臨床實踐中的廣泛應用。市場促進因素包括周邊動脈疾病和主動脈-髂動脈閉塞性疾病盛行率的上升、覆膜支架設計和材料的技術進步、微創血管內治療的日益普及以及微創血管內治療適應症的不斷擴大。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：全球覆膜支架市場：影響因素、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 全球噴射率：市場分析工具
  • 價格分析
  • 血管內修復術（FEVAR/BEVAR）的複雜發展、調節和合作路徑
  • 關於特定組件納入情況的澄清
  • 在FEVAR/BEVAR中使用橋接支架時，血管水平的腎動脈分叉
  • 每起案件平均使用設備數量

第4章 全球覆膜支架市場：細分市場分析、解剖部位、2021-2033 年及手術數量

  • 基於解剖區域的市佔率分析（2025 年和 2033 年）
  • 全球覆膜支架市場：依解剖部位分類，2021-2033年
    • 髂骨
    • AIOD（主動脈-髂動脈阻塞）
    • 表動脈 (SFA)
    • 複雜型腔內血管修復術
    • FEVAR
    • BEVAR
    • 腎臟血管

第5章 全球可用市場（SOM）中的覆膜支架市場：按器械類型和手術量分類的細分市場分析（2021-2033 年）

  • 按設備類型分類的市場佔有率分析，2025-2033 年
  • 全球覆膜支架市場：依器材類型分類，2021-2033年
    • 球囊擴張型
    • 自膨式覆膜支架（SX-CS）

第6章 全球可用市場（SOM）覆膜支架市場：以解剖部位分類的細分市場分析（2021-2033 年）及手術次數

  • 基於解剖區域的市佔率分析（2025 年和 2033 年）
  • 全球覆膜支架市場：依解剖部位分類，2021-2033年
    • 髂骨
    • AIOD（主動脈-髂動脈阻塞）
    • 表動脈 (SFA)
    • 複雜型腔內血管修復術
    • FEVAR
    • BEVAR
    • 腎臟血管

第7章 覆膜支架市場：按地區分類的細分市場分析（總市場規模和市場佔有率），2021-2033年

  • 2025-2033年區域市佔率分析
  • 區域市場概覽
  • 區域市場概述
  • 覆膜支架的區域市場佔有率（2025 年和 2033 年）：
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第8章 競爭情勢

  • 主要市場參與企業近期趨勢及影響分析
  • 公司分類
  • 企業市場占有率預估分析：依疾病狀態、按地區分類，2024/2025 年（%）
    • 2024/2025 年按通用總區和區域分類的企業市場占有率分析（%）
    • 2024年及2025年區域性及側向髂肌企業市場占有率分析（%）
    • 按AIOD和地區分類的企業市場占有率分析，2024/2025年（%）
    • 2024/2025年區域及表動脈（SFA）企業市場占有率分類）
    • 2024/2025 年區域及綜合 EVAR 中企業市場占有率分析 (%)
    • 2024/2025 年區域 FEVAR企業市場占有率分析 (%)
    • 按BEVAR和地區分類的企業市場占有率分析，2024/2025年（%）
    • 按腎血管系統和地區分類的企業市場占有率分析，2024/2025 年（%）
  • 其他新興和區域製造商名單
  • 公司簡介（球囊擴張型覆膜支架）
    • BD
    • Cook
    • Bentley InnoMed GmbH
    • Medtronic
    • Getinge AB
    • iVascular
    • WL Gore & Associates, Inc.
  • 公司簡介（自膨式覆膜支架）
    • WL Gore & Associates, Inc.
    • Solaris Endovascular
    • BD（Angiomed GmbH & Co. Medizintechnik KG）
    • LeMaitre Vascular, Inc.
    • Endologix LLC
    • Artivion, Inc
    • Merit Medical Systems
Product Code: GVR-4-68040-421-3

Covered Stent Market Summary

The global covered stent market size was estimated at USD 1.4 billion in 2025 and is projected to reach USD 2.1 billion by 2033, growing at a CAGR of 4.6% from 2026 to 2033. The growth is driven by the increasing prevalence of peripheral artery disease and complex aortoiliac occlusive conditions, rising volumes of endovascular procedures, and expanding preference for minimally invasive revascularization.

Advancements in covered stent design, including enhanced deliverability, radial strength, and long-term patency performance, continue to support broader clinical adoption. The key drivers of the market are the rising prevalence of peripheral artery and aortoiliac occlusive diseases, technological advancements in covered stent design and materials, increasing adoption of minimally invasive endovascular procedures and increasing adaptation of minimally invasive endovascular procedures.

Global Covered Stent Market Report Segmentation

This report forecasts volume & revenue growth at the global, regional, and country levels,and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global covered stent market report based on device type, anatomy, and region:

Total Addressable Market (TAM)

  • Anatomy Outlook (Unit Volume and Procedure Volume in Thousand Units; Revenue, USD Million, 2021 - 2033)
  • Iliac
    • Common Iliac
    • External Iliac
  • AIOD (Aortoiliac Occlusive Disease)
  • SFA (Superficial Femoral Artery)
  • Complex EVAR
  • FEVAR
  • BEVAR
  • Renal Vessel

Serviceable Obtainable Market (SOM)

  • Device Type Outlook (Unit Volume and Procedure Volume in Thousand Units; Revenue, USD Million, 2021 - 2033)
  • Balloon Expandable
    • Iliac
    • Common Iliac
    • External Iliac
    • AIOD (Aortoiliac Occlusive Disease)
    • Complex EVAR
    • FEVAR
    • BEVAR
    • Renal Vessel AIOD (Aortoiliac Occlusive Disease)
  • Self-expanding Covered Stent (SX-CS)
    • External Iliac
    • SFA (Superficial Femoral Artery)
    • Complex EVAR
    • FEVAR
    • BEVAR
  • Anatomy Outlook (Unit Volume and Procedure Volume in Thousand Units; Revenue, USD Million, 2021 - 2033)
  • Iliac
    • Common Iliac
    • External Iliac
  • AIOD (Aortoiliac Occlusive Disease)
  • SFA (Superficial Femoral Artery)
  • Complex EVAR
  • FEVAR
  • BEVAR
  • Renal Vessel
  • Regional Outlook at both TAM and SOM (Unit Volume and Procedure Volume in Thousand Units; Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment scope
    • 1.1.2. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation and Validation
  • 1.6. Model Details
  • 1.7. Research Assumptions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Device type outlook
    • 2.2.2. Anatomy outlook
  • 2.3. Competitive Insights

Chapter 3. Global Covered Stent Market Variables, Trends and Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Global Ejection Fraction: Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.2. PESTLE Analysis
  • 3.4. Pricing Analysis
    • 3.4.1. Average Selling Price (ASP) by Device Type
    • 3.4.2. Average Selling Price (ASP) by Region
    • 3.4.3. Estimated Average Selling Price (ASP) Device X Anatomy, 2024 (USD)
  • 3.5. Development, Regulatory & Partnership Pathways for Complex EVAR (FEVAR / BEVAR)
    • 3.5.1. Clinical Evidence Requirements
      • 3.5.1.1. Typical evidence expectations by region
      • 3.5.1.2. Study design and endpoint considerations
      • 3.5.1.3. Study design and endpoint considerations
      • 3.5.1.4. Role of registries and real-world evidence
    • 3.5.2. Regulatory Pathways & Implications, U.S. and Europe
      • 3.5.2.1. Applicable approval pathways
      • 3.5.2.2. Timelines and complexity drivers
      • 3.5.2.3. Strategic implications
    • 3.5.3. Financial implications of different development pathways
      • 3.5.3.1. Key development and validation cost drivers for complex EVAR, FEVAR, BEVAR devices
      • 3.5.3.2. Clinical and regulatory investment considerations
      • 3.5.3.3. Trade-offs between pathways
      • 3.5.3.4. Post-approval cost implications
    • 3.5.4. Partnership & Collaboration Models
      • 3.5.4.1. Prevalence of partnerships with AAA platform manufacturers
      • 3.5.4.2. Common collaboration structures (codevelopment, licensing, distribution)
      • 3.5.4.3. Strategic rationale and adoption impact
      • 3.5.4.4. Advantages and limitations of partnership approaches
    • 3.5.5. Bridging Stent Strategy Approaches
      • 3.5.5.1. Platform-specific vs platform-agnostic design strategies
      • 3.5.5.2. Adoption and compatibility drivers
      • 3.5.5.3. Commercial positioning approaches
      • 3.5.5.4. Strategic implications for market entry and scalability
  • 3.6. Clarification on inclusion of Specific Components
  • 3.7. Vessel-Level Renal Artery Split for FEVAR/BEVAR Bridging Stent Usage
  • 3.8. Average Device Utilization per Case

Chapter 4. Global Total Addressable Market (TAM) Covered Stent Market Segment Analysis, By Anatomy, 2021-2033 (USD Million, Unit Volume and Procedure Volume in Thousand Units)

  • 4.1. Definition and Scope
  • 4.2. Anatomy Market Share Analysis, 2025 and 2033
  • 4.3. Segment Dashboard
  • 4.4. Global Covered Stent Market, By Anatomy, 2021 to 2033
    • 4.4.1. Iliac
      • 4.4.1.1. Iliac Market Estimates and Forecasts 2021 To 2033 (USD Million)
        • 4.4.1.1.1. Common Iliac
          • 4.4.1.1.1.1. Common Iliac Market Estimates and Forecasts 2021 To 2033 (USD Million)
        • 4.4.1.1.2. External Iliac
          • 4.4.1.1.2.1. External Iliac Market Estimates and Forecasts 2021 To 2033 (USD Million)
    • 4.4.2. AIOD (Aortoiliac Occlusive Disease)
      • 4.4.2.1. AIOD (Aortoiliac Occlusive Disease) Market Estimates and Forecasts 2021 To 2033 (USD Million)
    • 4.4.3. SFA (Superficial Femoral Artery)
      • 4.4.3.1. SFA (Superficial Femoral Artery) Market Estimates and Forecasts 2021 To 2033 (USD Million)
    • 4.4.4. Complex EVAR
      • 4.4.4.1. Complex EVAR Market Estimates and Forecasts 2021 To 2033 (USD Million)
    • 4.4.5. FEVAR
      • 4.4.5.1. FEVAR Market Estimates and Forecasts 2021 To 2033 (USD Million)
    • 4.4.6. BEVAR
      • 4.4.6.1. BEVAR Market Estimates and Forecasts 2021 To 2033 (USD Million)
    • 4.4.7. Renal Vessel
      • 4.4.7.1. Renal Vessel Market Estimates and Forecasts 2021 To 2033 (USD Million)

Chapter 5. Global Serviceable Obtainable Market (SOM) Covered Stent Market Segment Analysis, By Device Type, 2021-2033 (USD Million, Unit Volume and Procedure Volume in Thousand Units)

  • 5.1. Definition and Scope
  • 5.2. Device Type Market Share Analysis, 2025 and 2033
  • 5.3. Segment Dashboard
  • 5.4. Global Covered Stent Market, By Device Type, 2021 to 2033
    • 5.4.1. Balloon Expandable
      • 5.4.1.1. Balloon Expandable Market Estimates and Forecasts 2021 To 2033 (USD Million)
      • 5.4.1.2. Balloon Expandable Market Estimates and Forecasts 2021 To 2033 (Unit Volume and Procedure Volume, In Thousand Units)
        • 5.4.1.2.1. Iliac
          • 5.4.1.2.1.1. Iliac Market Estimates and Forecasts 2021 To 2033 (USD Million)
          • 5.4.1.2.1.2. Iliac Market Estimates and Forecasts 2021 To 2033 (Unit Volume and Procedure Volume, In Thousand Units)
            • 5.4.1.2.1.2.1. Common Iliac
              • 5.4.1.2.1.2.1.1. Common Iliac Market Estimates and Forecasts 2021 To 2033 (USD Million)
              • 5.4.1.2.1.2.1.2. Common Iliac Market Estimates and Forecasts 2021 To 2033 (Unit Volume and Procedure Volume, In Thousand Units)
            • 5.4.1.2.1.2.2. External Iliac
              • 5.4.1.2.1.2.2.1. External Iliac Market Estimates and Forecasts 2021 To 2033 (USD Million)
              • 5.4.1.2.1.2.2.2. External Iliac Market Estimates and Forecasts 2021 To 2033 (Unit Volume and Procedure Volume, In Thousand Units)
        • 5.4.1.2.2. AIOD (Aortoiliac Occlusive Disease)
          • 5.4.1.2.2.1. AIOD (Aortoiliac Occlusive Disease) Market Estimates and Forecasts 2021 To 2033 (USD Million)
          • 5.4.1.2.2.2. AIOD (Aortoiliac Occlusive Disease) Market Estimates and Forecasts 2021 To 2033 (Unit Volume and Procedure Volume, In Thousand Units)
        • 5.4.1.2.3. Complex EVAR
          • 5.4.1.2.3.1. Complex EVAR Market Estimates and Forecasts 2021 To 2033 (USD Million)
          • 5.4.1.2.3.2. Complex EVAR Market Estimates and Forecasts 2021 To 2033 (Unit Volume and Procedure Volume, In Thousand Units)
        • 5.4.1.2.4. FEVAR
          • 5.4.1.2.4.1. FEVAR Market Estimates and Forecasts 2021 To 2033 (USD Million)
          • 5.4.1.2.4.2. FEVAR Market Estimates and Forecasts 2021 To 2033 (Unit Volume and Procedure Volume, In Thousand Units)
        • 5.4.1.2.5. BEVAR
          • 5.4.1.2.5.1. BEVAR Market Estimates and Forecasts 2021 To 2033 (USD Million)
          • 5.4.1.2.5.2. BEVAR Market Estimates and Forecasts 2021 To 2033 (Unit Volume and Procedure Volume, In Thousand Units)
        • 5.4.1.2.6. Renal Vessel AIOD (Aortoiliac Occlusive Disease)
          • 5.4.1.2.6.1. Renal Vessel AIOD (Aortoiliac Occlusive Disease) Market Estimates and Forecasts 2021 To 2033 (USD Million)
          • 5.4.1.2.6.2. Renal Vessel AIOD (Aortoiliac Occlusive Disease) Market Estimates and Forecasts 2021 To 2033 (Unit Volume and Procedure Volume, In Thousand Units)
    • 5.4.2. Self-expanding Covered Stent (SX-CS)
      • 5.4.2.1. Self-expanding Covered Stent (SX-CS) Market Estimates and Forecasts 2021 To 2033 (USD Million)
      • 5.4.2.2. Self-expanding Covered Stent (SX-CS) Market Estimates and Forecasts 2021 To 2033 (Unit Volume and Procedure Volume, In Thousand Units)
        • 5.4.2.2.1. External Iliac
          • 5.4.2.2.1.1. External Iliac Market Estimates and Forecasts 2021 To 2033 (USD Million)
          • 5.4.2.2.1.2. External Iliac Market Estimates and Forecasts 2021 To 2033 (Unit Volume and Procedure Volume, In Thousand Units)
        • 5.4.2.2.2. SFA (Superficial Femoral Artery)
          • 5.4.2.2.2.1. SFA (Superficial Femoral Artery) Market Estimates and Forecasts 2021 To 2033 (USD Million)
          • 5.4.2.2.2.2. SFA (Superficial Femoral Artery) Market Estimates and Forecasts 2021 To 2033 (Unit Volume and Procedure Volume, In Thousand Units)
        • 5.4.2.2.3. Complex EVAR
          • 5.4.2.2.3.1. Complex EVAR Market Estimates and Forecasts 2021 To 2033 (USD Million)
          • 5.4.2.2.3.2. Complex EVAR Market Estimates and Forecasts 2021 To 2033 (Unit Volume and Procedure Volume, In Thousand Units)
        • 5.4.2.2.4. FEVAR
          • 5.4.2.2.4.1. FEVAR Market Estimates and Forecasts 2021 To 2033 (USD Million)
          • 5.4.2.2.4.2. FEVAR Market Estimates and Forecasts 2021 To 2033 (Unit Volume and Procedure Volume, In Thousand Units)
        • 5.4.2.2.5. BEVAR
          • 5.4.2.2.5.1. BEVAR Market Estimates and Forecasts 2021 To 2033 (USD Million)
          • 5.4.2.2.5.2. BEVAR Market Estimates and Forecasts 2021 To 2033 (Unit Volume and Procedure Volume, In Thousand Units)

Chapter 6. Global Serviceable Obtainable Market (SOM) Covered Stent Market Segment Analysis, By Anatomy, 2021-2033 (USD Million, Unit Volume and Procedure Volume in Thousand Units)

  • 6.1. Definition and Scope
  • 6.2. Anatomy Market Share Analysis, 2025 and 2033
  • 6.3. Segment Dashboard
  • 6.4. Global Covered Stent Market, By Anatomy, 2021 to 2033
    • 6.4.1. Iliac
      • 6.4.1.1. Iliac Market Estimates and Forecasts 2021 To 2033 (USD Million)
      • 6.4.1.2. Iliac Market Estimates and Forecasts 2021 To 2033 (Procedure Volume, In Thousand Units)
        • 6.4.1.2.1. Common Iliac
          • 6.4.1.2.1.1. Common Iliac Market Estimates and Forecasts 2021 To 2033 (USD Million)
          • 6.4.1.2.1.2. Common Iliac Market Estimates and Forecasts 2021 To 2033 (Procedure Volume, In Thousand Units)
        • 6.4.1.2.2. External Iliac
          • 6.4.1.2.2.1. External Iliac Market Estimates and Forecasts 2021 To 2033 (USD Million)
          • 6.4.1.2.2.2. External Iliac Market Estimates and Forecasts 2021 To 2033 (Procedure Volume, In Thousand Units)
    • 6.4.2. AIOD (Aortoiliac Occlusive Disease)
      • 6.4.2.1. AIOD (Aortoiliac Occlusive Disease) Market Estimates and Forecasts 2021 To 2033 (USD Million)
      • 6.4.2.2. AIOD (Aortoiliac Occlusive Disease) Market Estimates and Forecasts 2021 To 2033 (Procedure Volume, In Thousand Units)
    • 6.4.3. SFA (Superficial Femoral Artery)
      • 6.4.3.1. SFA (Superficial Femoral Artery) Market Estimates and Forecasts 2021 To 2033 (USD Million)
      • 6.4.3.2. SFA (Superficial Femoral Artery) Market Estimates and Forecasts 2021 To 2033 (Procedure Volume, In Thousand Units)
    • 6.4.4. Complex EVAR
      • 6.4.4.1. Complex EVAR Market Estimates and Forecasts 2021 To 2033 (USD Million)
      • 6.4.4.2. Complex EVAR Market Estimates and Forecasts 2021 To 2033 (Procedure Volume, In Thousand Units)
    • 6.4.5. FEVAR
      • 6.4.5.1. FEVAR Market Estimates and Forecasts 2021 To 2033 (USD Million)
      • 6.4.5.2. FEVAR Market Estimates and Forecasts 2021 To 2033 (Procedure Volume, In Thousand Units)
    • 6.4.6. BEVAR
      • 6.4.6.1. BEVAR Market Estimates and Forecasts 2021 To 2033 (USD Million)
      • 6.4.6.2. BEVAR Market Estimates and Forecasts 2021 To 2033 (Procedure Volume, In Thousand Units)
    • 6.4.7. Renal Vessel
      • 6.4.7.1. Renal Vessel Market Estimates and Forecasts 2021 To 2033 (USD Million)
      • 6.4.7.2. Renal Vessel Market Estimates and Forecasts 2021 To 2033 (Procedure Volume, In Thousand Units)

Chapter 7. Covered Stent Market Segment Analysis (TAM and SOM), By Region, 2021- 2033 (USD Million)

  • 7.1. Regional Market Share Analysis, 2025 And 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Regional Market Snapshot
  • 7.4. Covered Stent Market Share by Region, 2025 And 2033:
  • 7.5. North America
    • 7.5.1. North America Covered Stent Market, 2021 - 2033 (USD Million)
    • 7.5.2. U.S.
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Scenario
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. U.S. Covered Stent Market, 2021 - 2033 (USD Million)
      • 7.5.2.5. U.S. Covered Stent Market, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
    • 7.5.3. Canada
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Scenario
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Canada Covered Stent Market, 2021 - 2033 (USD Million)
      • 7.5.3.5. Canada Covered Stent Market, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Scenario
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Mexico covered stent market, 2021 - 2033 (USD Million)
      • 7.5.4.5. Mexico Covered Stent Market, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
  • 7.6. Europe
    • 7.6.1. Europe Covered Stent Market, 2021 - 2033 (USD Million)
    • 7.6.2. UK
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Scenario
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. UK Covered Stent Market, 2021 - 2033 (USD Million)
      • 7.6.2.5. UK Covered Stent Market, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
    • 7.6.3. Germany
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Scenario
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Germany Covered Stent Market, 2021 - 2033 (USD Million)
      • 7.6.3.5. Germany Covered Stent Market, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
    • 7.6.4. France
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Scenario
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. France Covered Stent Market, 2021 - 2033 (USD Million)
      • 7.6.4.5. France Covered Stent Market, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
    • 7.6.5. Italy
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Scenario
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Italy Covered Stent Market, 2021 - 2033 (USD Million)
      • 7.6.5.5. Italy Covered Stent Market, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
    • 7.6.6. Spain
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Scenario
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. Spain Covered Stent Market, 2021 - 2033 (USD Million)
      • 7.6.6.5. Spain Covered Stent Market, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
    • 7.6.7. Norway
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Scenario
      • 7.6.7.3. Competitive Scenario
      • 7.6.7.4. Norway Covered Stent Market, 2021 - 2033 (USD Million)
      • 7.6.7.5. Norway Covered Stent Market, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
    • 7.6.8. Sweden
      • 7.6.8.1. Key Country Dynamics
      • 7.6.8.2. Regulatory Scenario
      • 7.6.8.3. Competitive Scenario
      • 7.6.8.4. Sweden Covered Stent Market, 2021 - 2033 (USD Million)
      • 7.6.8.5. Sweden Covered Stent Market, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
    • 7.6.9. Denmark
      • 7.6.9.1. Key Country Dynamics
      • 7.6.9.2. Regulatory Scenario
      • 7.6.9.3. Competitive Scenario
      • 7.6.9.4. Denmark Covered Stent Market, 2021 - 2033 (USD Million)
      • 7.6.9.5. Denmark Covered Stent Market, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key Country Dynamics
      • 7.7.1.2. Regulatory Scenario
      • 7.7.1.3. Competitive Scenario
      • 7.7.1.4. Japan Covered Stent Market, 2021 - 2033 (USD Million)
      • 7.7.1.5. Japan Covered Stent Market, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
    • 7.7.2. China
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Scenario
      • 7.7.2.3. Competitive Scenario
      • 7.7.2.4. China Covered Stent Market, 2021 - 2033 (USD Million)
      • 7.7.2.5. China Covered Stent Market, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
    • 7.7.3. India
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Scenario
      • 7.7.3.3. Competitive Scenario
      • 7.7.3.4. India Covered Stent Market, 2021 - 2033 (USD Million)
      • 7.7.3.5. India Covered Stent Market, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
    • 7.7.4. Australia
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Regulatory Scenario
      • 7.7.4.3. Competitive Scenario
      • 7.7.4.4. Australia Covered Stent Market, 2021 - 2033 (USD Million)
      • 7.7.4.5. Australia Covered Stent Market, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
    • 7.7.5. South Korea
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Regulatory Scenario
      • 7.7.5.3. Competitive Scenario
      • 7.7.5.4. South Korea Covered Stent Market, 2021 - 2033 (USD Million)
      • 7.7.5.5. South Korea Covered Stent Market, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
    • 7.7.6. Thailand
      • 7.7.6.1. Key Country Dynamics
      • 7.7.6.2. Regulatory Scenario
      • 7.7.6.3. Competitive Scenario
      • 7.7.6.4. Thailand Covered Stent Market, 2021 - 2033 (USD Million)
      • 7.7.6.5. Thailand Covered Stent Market, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key Country Dynamics
      • 7.8.1.2. Regulatory Scenario
      • 7.8.1.3. Competitive Scenario
      • 7.8.1.4. Brazil Covered Stent Market, 2021 - 2033 (USD Million)
      • 7.8.1.5. Brazil Covered Stent Market, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
    • 7.8.2. Argentina
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Scenario
      • 7.8.2.3. Competitive Scenario
      • 7.8.2.4. Argentina Covered Stent Market, 2021 - 2033 (USD Million)
      • 7.8.2.5. Argentina Covered Stent Market, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key Country Dynamics
      • 7.9.1.2. Regulatory Scenario
      • 7.9.1.3. Competitive Scenario
      • 7.9.1.4. South Africa Covered Stent Market, 2021 - 2033 (USD Million)
      • 7.9.1.5. South Africa Covered Stent Market, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key Country Dynamics
      • 7.9.2.2. Regulatory Scenario
      • 7.9.2.3. Competitive Scenario
      • 7.9.2.4. Saudi Arabia Covered Stent Market, 2021 - 2033 (USD Million)
      • 7.9.2.5. Saudi Arabia Covered Stent Market, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
    • 7.9.3. UAE
      • 7.9.3.1. Key Country Dynamics
      • 7.9.3.2. Regulatory Scenario
      • 7.9.3.3. Competitive Scenario
      • 7.9.3.4. UAE Covered Stent Market, 2021 - 2033 (USD Million)
      • 7.9.3.5. UAE Covered Stent Market, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key Country Dynamics
      • 7.9.4.2. Regulatory Scenario
      • 7.9.4.3. Competitive Scenario
      • 7.9.4.4. Kuwait Covered Stent Market, 2021 - 2033 (USD Million)
      • 7.9.4.5. Kuwait Covered Stent Market, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments and Impact Analysis, By Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Estimated Company Market Share Analysis, By Anatomy, By Region, 2024/2025 (%)
    • 8.3.1. Estimated company market share analysis by Common Iliac, by Region 2024/2025 (%)
    • 8.3.2. Estimated company market share analysis by external Iliac, by Region 2024/2025 (%)
    • 8.3.3. Estimated company market share analysis by AIOD, by Region 2024/2025 (%)
    • 8.3.4. Estimated company market share analysis by SFA (Superficial Femoral Artery), by Region 2024/2025 (%)
    • 8.3.5. Estimated company market share analysis by Complex EVAR, by Region 2024/2025 (%)
    • 8.3.6. Estimated company market share analysis by FEVAR, by Region 2024/2025 (%)
    • 8.3.7. Estimated company market share analysis by BEVAR, by Region 2024/2025 (%)
    • 8.3.8. Estimated company market share analysis by Renal vessel, by Region 2024/2025 (%)
  • 8.4. List of Other Emerging and Regional Manufacturers
  • 8.5. Company Profiles (Balloon-Expandable Covered Stent)
    • 8.5.1. BD
      • 8.5.1.1. Company Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Cook
      • 8.5.2.1. Company Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Bentley InnoMed GmbH
      • 8.5.3.1. Company Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Medtronic
      • 8.5.4.1. Company Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Getinge AB
      • 8.5.5.1. Company Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. iVascular
      • 8.5.6.1. Company Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. W. L. Gore & Associates, Inc.
      • 8.5.7.1. Company Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
  • 8.6. Company Profiles (Self-Expanding Covered Stent)
    • 8.6.1. W. L. Gore & Associates, Inc.
      • 8.6.1.1. Company Overview
      • 8.6.1.2. Financial Performance
      • 8.6.1.3. Product Benchmarking
      • 8.6.1.4. Strategic Initiatives
    • 8.6.2. Solaris Endovascular
      • 8.6.2.1. Company Overview
      • 8.6.2.2. Financial Performance
      • 8.6.2.3. Product Benchmarking
      • 8.6.2.4. Strategic Initiatives
    • 8.6.3. BD (Angiomed GmbH & Co. Medizintechnik KG)
      • 8.6.3.1. Company Overview
      • 8.6.3.2. Financial Performance
      • 8.6.3.3. Product Benchmarking
      • 8.6.3.4. Strategic Initiatives
    • 8.6.4. LeMaitre Vascular, Inc.
      • 8.6.4.1. Company Overview
      • 8.6.4.2. Financial Performance
      • 8.6.4.3. Product Benchmarking
      • 8.6.4.4. Strategic Initiatives
    • 8.6.5. Endologix LLC
      • 8.6.5.1. Company Overview
      • 8.6.5.2. Financial Performance
      • 8.6.5.3. Product Benchmarking
      • 8.6.5.4. Strategic Initiatives
    • 8.6.6. Artivion, Inc
      • 8.6.6.1. Company Overview
      • 8.6.6.2. Financial Performance
      • 8.6.6.3. Product Benchmarking
      • 8.6.6.4. Strategic Initiatives
    • 8.6.7. Merit Medical Systems
      • 8.6.7.1. Company Overview
      • 8.6.7.2. Financial Performance
      • 8.6.7.3. Product Benchmarking
      • 8.6.7.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global Covered Stent Market, By Device Type, 2021 - 2033 (USD Million)
  • Table 4 Global Covered Stent Market, By Device Type, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
  • Table 5 Global Covered Stent Market, By Anatomy, 2021 - 2033 (USD Million)
  • Table 6 Global Covered Stent Market, By Anatomy, 2021 - 2033 (Procedure Volume, In Thousand Units)
  • Table 7 Global Covered Stent Market, By Region, 2021 - 2033 (USD Million)
  • Table 8 North America Covered Stent Market, By Country, 2021 - 2033 (USD Million)
  • Table 9 North America Covered Stent Market, By Device Type, 2021 - 2033 (USD Million)
  • Table 10 North America Covered Stent Market, By Device Type, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
  • Table 11 North America Covered Stent Market, By Anatomy, 2021 - 2033 (USD Million)
  • Table 12 North America Covered Stent Market, By Anatomy, 2021 - 2033 (Procedure Volume, In Thousand Units)
  • Table 13 U.S. Covered Stent Market, By Device Type, 2021 - 2033 (USD Million)
  • Table 14 U.S. Covered Stent Market, By Device Type, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
  • Table 15 U.S. Covered Stent Market, By Anatomy, 2021 - 2033 (USD Million)
  • Table 16 U.S. Covered Stent Market, By Anatomy, 2021 - 2033 (Procedure Volume, In Thousand Units)
  • Table 17 Canada Covered Stent Market, By Device Type, 2021 - 2033 (USD Million)
  • Table 18 Canada Covered Stent Market, By Device Type, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
  • Table 19 Canada Covered Stent Market, By Anatomy, 2021 - 2033 (USD Million)
  • Table 20 Canada Covered Stent Market, By Anatomy, 2021 - 2033 (Procedure Volume, In Thousand Units)
  • Table 21 Mexico Covered Stent Market, By Device Type, 2021 - 2033 (USD Million)
  • Table 22 Mexico Covered Stent Market, By Device Type, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
  • Table 23 Mexico Covered Stent Market, By Anatomy, 2021 - 2033 (USD Million)
  • Table 24 Mexico Covered Stent Market, By Anatomy, 2021 - 2033 (Procedure Volume, In Thousand Units)
  • Table 25 Europe Covered Stent Market, by Country, 2021 - 2033 (USD Million)
  • Table 26 Europe Covered Stent Market, By Device Type, 2021 - 2033 (USD Million)
  • Table 27 Europe Covered Stent Market, By Device Type, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
  • Table 28 Europe Covered Stent Market, By Anatomy, 2021 - 2033 (USD Million)
  • Table 29 Europe Covered Stent Market, By Anatomy, 2021 - 2033 (Procedure Volume, In Thousand Units)
  • Table 30 UK Covered Stent Market, By Device Type, 2021 - 2033 (USD Million)
  • Table 31 UK Covered Stent Market, By Device Type, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
  • Table 32 UK Covered Stent Market, By Anatomy, 2021 - 2033 (USD Million)
  • Table 33 UK Covered Stent Market, By Anatomy, 2021 - 2033 (Procedure Volume, In Thousand Units)
  • Table 34 Germany Covered Stent Market, By Device Type, 2021 - 2033 (USD Million)
  • Table 35 Germany Covered Stent Market, By Device Type, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
  • Table 36 Germany Covered Stent Market, By Anatomy, 2021 - 2033 (USD Million)
  • Table 37 Germany Covered Stent Market, By Anatomy, 2021 - 2033 (Procedure Volume, In Thousand Units)
  • Table 38 France Covered Stent Market, By Device Type, 2021 - 2033 (USD Million)
  • Table 39 France Covered Stent Market, By Device Type, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
  • Table 40 France Covered Stent Market, By Anatomy, 2021 - 2033 (USD Million)
  • Table 41 France Covered Stent Market, By Anatomy, 2021 - 2033 (Procedure Volume, In Thousand Units)
  • Table 42 Italy Covered Stent Market, By Device Type, 2021 - 2033 (USD Million)
  • Table 43 Italy Covered Stent Market, By Device Type, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
  • Table 44 Italy Covered Stent Market, By Anatomy, 2021 - 2033 (USD Million)
  • Table 45 Italy Covered Stent Market, By Anatomy, 2021 - 2033 (Procedure Volume, In Thousand Units)
  • Table 46 Spain Covered Stent Market, By Device Type, 2021 - 2033 (USD Million)
  • Table 47 Spain Covered Stent Market, By Device Type, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
  • Table 48 Spain Covered Stent Market, By Anatomy, 2021 - 2033 (USD Million)
  • Table 49 Spain Covered Stent Market, By Anatomy, 2021 - 2033 (Procedure Volume, In Thousand Units)
  • Table 50 Denmark Covered Stent Market, By Device Type, 2021 - 2033 (USD Million)
  • Table 51 Denmark Covered Stent Market, By Device Type, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
  • Table 52 Denmark Covered Stent Market, By Anatomy, 2021 - 2033 (USD Million)
  • Table 53 Denmark Covered Stent Market, By Anatomy, 2021 - 2033 (Procedure Volume, In Thousand Units)
  • Table 54 Sweden Covered Stent Market, By Device Type, 2021 - 2033 (USD Million)
  • Table 55 Sweden Covered Stent Market, By Device Type, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
  • Table 56 Sweden Covered Stent Market, By Anatomy, 2021 - 2033 (USD Million)
  • Table 57 Sweden Covered Stent Market, By Anatomy, 2021 - 2033 (Procedure Volume, In Thousand Units)
  • Table 58 Norway Covered Stent Market, By Device Type, 2021 - 2033 (USD Million)
  • Table 59 Norway Covered Stent Market, By Device Type, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
  • Table 60 Norway Covered Stent Market, By Anatomy, 2021 - 2033 (USD Million)
  • Table 61 Norway Covered Stent Market, By Anatomy, 2021 - 2033 (Procedure Volume, In Thousand Units)
  • Table 62 Asia Pacific Covered Stent Market, by Country, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific Covered Stent Market, By Device Type, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific Covered Stent Market, By Device Type, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
  • Table 65 Asia Pacific Covered Stent Market, By Anatomy, 2021 - 2033 (USD Million)
  • Table 66 Asia Pacific Covered Stent Market, By Anatomy, 2021 - 2033 (Procedure Volume, In Thousand Units)
  • Table 67 Japan Covered Stent Market, By Device Type, 2021 - 2033 (USD Million)
  • Table 68 Japan Covered Stent Market, By Device Type, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
  • Table 69 Japan Covered Stent Market, By Anatomy, 2021 - 2033 (USD Million)
  • Table 70 Japan Covered Stent Market, By Anatomy, 2021 - 2033 (Procedure Volume, In Thousand Units)
  • Table 71 China Covered Stent Market, By Device Type, 2021 - 2033 (USD Million)
  • Table 72 China Covered Stent Market, By Device Type, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
  • Table 73 China Covered Stent Market, By Anatomy, 2021 - 2033 (USD Million)
  • Table 74 China Covered Stent Market, By Anatomy, 2021 - 2033 (Procedure Volume, In Thousand Units)
  • Table 75 India Covered Stent Market, By Device Type, 2021 - 2033 (USD Million)
  • Table 76 India Covered Stent Market, By Device Type, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
  • Table 77 India Covered Stent Market, By Anatomy, 2021 - 2033 (USD Million)
  • Table 78 India Covered Stent Market, By Anatomy, 2021 - 2033 (Procedure Volume, In Thousand Units)
  • Table 79 Australia Covered Stent Market, By Device Type, 2021 - 2033 (USD Million)
  • Table 80 Australia Covered Stent Market, By Device Type, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
  • Table 81 Australia Covered Stent Market, By Anatomy, 2021 - 2033 (USD Million)
  • Table 82 Australia Covered Stent Market, By Anatomy, 2021 - 2033 (Procedure Volume, In Thousand Units)
  • Table 83 Thailand Covered Stent Market, By Device Type, 2021 - 2033 (USD Million)
  • Table 84 Thailand Covered Stent Market, By Device Type, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
  • Table 85 Thailand Covered Stent Market, By Anatomy, 2021 - 2033 (USD Million)
  • Table 86 Thailand Covered Stent Market, By Anatomy, 2021 - 2033 (Procedure Volume, In Thousand Units)
  • Table 87 South Korea Covered Stent Market, By Device Type, 2021 - 2033 (USD Million)
  • Table 88 South Korea Covered Stent Market, By Device Type, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
  • Table 89 South Korea Covered Stent Market, By Anatomy, 2021 - 2033 (USD Million)
  • Table 90 South Korea Covered Stent Market, By Anatomy, 2021 - 2033 (Procedure Volume, In Thousand Units)
  • Table 91 Latin America Covered Stent Market, by Country, 2021 - 2033 (USD Million)
  • Table 92 Latin America Covered Stent Market, By Device Type, 2021 - 2033 (USD Million)
  • Table 93 Latin America Covered Stent Market, By Device Type, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
  • Table 94 Latin America Covered Stent Market, By Anatomy, 2021 - 2033 (USD Million)
  • Table 95 Latin America Covered Stent Market, By Anatomy, 2021 - 2033 (Procedure Volume, In Thousand Units)
  • Table 96 Brazil Covered Stent Market, By Device Type, 2021 - 2033 (USD Million)
  • Table 97 Brazil Covered Stent Market, By Device Type, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
  • Table 98 Brazil Covered Stent Market, By Anatomy, 2021 - 2033 (USD Million)
  • Table 99 Brazil Covered Stent Market, By Anatomy, 2021 - 2033 (Procedure Volume, In Thousand Units)
  • Table 100 Argentina Covered Stent Market, By Device Type, 2021 - 2033 (USD Million)
  • Table 101 Argentina Covered Stent Market, By Device Type, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
  • Table 102 Argentina Covered Stent Market, By Anatomy, 2021 - 2033 (USD Million)
  • Table 103 Argentina Covered Stent Market, By Anatomy, 2021 - 2033 (Procedure Volume, In Thousand Units)
  • Table 104 Middle East and Africa Covered Stent Market, by Country, 2021 - 2033 (USD Million)
  • Table 105 Middle East and Africa Covered Stent Market, By Device Type, 2021 - 2033 (USD Million)
  • Table 106 Middle East and Africa Covered Stent Market, By Device Type, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
  • Table 107 Middle East and Africa Covered Stent Market, By Anatomy, 2021 - 2033 (USD Million)
  • Table 108 Middle East and Africa Covered Stent Market, By Anatomy, 2021 - 2033 (Procedure Volume, In Thousand Units)
  • Table 109 South Africa Covered Stent Market, By Device Type, 2021 - 2033 (USD Million)
  • Table 110 South Africa Covered Stent Market, By Device Type, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
  • Table 111 South Africa Covered Stent Market, By Anatomy, 2021 - 2033 (USD Million)
  • Table 112 South Africa Covered Stent Market, By Anatomy, 2021 - 2033 (Procedure Volume, In Thousand Units)
  • Table 113 Saudi Arabia Covered Stent Market, By Device Type, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia Covered Stent Market, By Device Type, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
  • Table 115 Saudi Arabia Covered Stent Market, By Anatomy, 2021 - 2033 (USD Million)
  • Table 116 Saudi Arabia Covered Stent Market, By Anatomy, 2021 - 2033 (Procedure Volume, In Thousand Units)
  • Table 117 UAE Covered Stent Market, By Device Type, 2021 - 2033 (USD Million)
  • Table 118 UAE Covered Stent Market, By Device Type, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
  • Table 119 UAE Covered Stent Market, By Anatomy, 2021 - 2033 (USD Million)
  • Table 120 UAE Covered Stent Market, By Anatomy, 2021 - 2033 (Procedure Volume, In Thousand Units)
  • Table 121 Kuwait Covered Stent Market, By Device Type, 2021 - 2033 (USD Million)
  • Table 122 Kuwait Covered Stent Market, By Device Type, 2021 - 2033 (Unit Volume and Procedure Volume, In Thousand Units)
  • Table 123 Kuwait Covered Stent Market, By Anatomy, 2021 - 2033 (USD Million)
  • Table 124 Kuwait Covered Stent Market, By Anatomy, 2021 - 2033 (Procedure Volume, In Thousand Units)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value-Chain-Based Sizing And Forecasting
  • Fig. 6 QFD Modeling For Market Share Assessment
  • Fig. 7 Market Formulation And Validation
  • Fig. 8 Global Covered Stent Market: Outlook
  • Fig. 9 Global Covered Stent Competitive Insights
  • Fig. 10 Parent Market Outlook
  • Fig. 11 Ancillary Market Outlook
  • Fig. 12 Global Covered Stent Market Driver Impact
  • Fig. 13 Global Covered Stent Market Restraint Impact
  • Fig. 14 Porter's Analysis
  • Fig. 15 PESTLE Analysis
  • Fig. 16 Global Covered Stent Market: Device Type Movement Analysis
  • Fig. 17 Global Covered Stent Market: Device Type Outlook and Key Takeaways
  • Fig. 18 Balloon Expandable Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume and Procedure Volume in Thousand Units)
  • Fig. 19 Iliac Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume and Procedure Volume in Thousand Units)
  • Fig. 20 Common Iliac Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume and Procedure Volume in Thousand Units)
  • Fig. 21 External Iliac Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume and Procedure Volume in Thousand Units)
  • Fig. 22 AIOD (Aortoiliac Occlusive Disease) Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume and Procedure Volume in Thousand Units)
  • Fig. 23 Complex EVAR Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume and Procedure Volume in Thousand Units)
  • Fig. 24 FEVAR Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume and Procedure Volume in Thousand Units)
  • Fig. 25 BEVAR Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume and Procedure Volume in Thousand Units)
  • Fig. 26 Renal Vessel AIOD (Aortoiliac Occlusive Disease) Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume and Procedure Volume in Thousand Units)
  • Fig. 27 Self-expanding Covered Stent (SX-CS) Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume and Procedure Volume in Thousand Units)
  • Fig. 28 External Iliac Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume and Procedure Volume in Thousand Units)
  • Fig. 29 SFA (Superficial Femoral Artery) Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume and Procedure Volume in Thousand Units)
  • Fig. 30 Complex EVAR Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume and Procedure Volume in Thousand Units)
  • Fig. 31 FEVAR Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume and Procedure Volume in Thousand Units)
  • Fig. 32 BEVAR Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume and Procedure Volume in Thousand Units)
  • Fig. 33 Global Covered Stent Market: Anatomy Movement Analysis
  • Fig. 34 Global Covered Stent Market: Anatomy Outlook and Key Takeaways
  • Fig. 35 Iliac Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million and Procedure Volume In Thousand Units)
  • Fig. 36 Common Iliac Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million and Procedure Volume In Thousand Units)
  • Fig. 37 External Iliac Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million and Procedure Volume In Thousand Units)
  • Fig. 38 AIOD (Aortoiliac Occlusive Disease) Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million and Procedure Volume In Thousand Units)
  • Fig. 39 SFA (Superficial Femoral Artery) Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million and Procedure Volume In Thousand Units)
  • Fig. 40 Complex EVAR Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million and Procedure Volume In Thousand Units)
  • Fig. 41 FEVAR Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million and Procedure Volume In Thousand Units)
  • Fig. 42 BEVAR Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million and Procedure Volume In Thousand Units)
  • Fig. 43 Renal Vessel Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million and Procedure Volume In Thousand Units)
  • Fig. 44 Global Covered Stent Market: Regional Movement Analysis
  • Fig. 45 Global Covered Stent Market: Regional Outlook and Key Takeaways
  • Fig. 46 North America Covered Stent Market Estimates and Forecasts, 2021 - 2033 (Revenue in USD Million and Procedure Volume in Thousand Units)
  • Fig. 47 Key Country Dynamics
  • Fig. 48 U.S. Covered Stent Market Estimates and Forecasts, 2021 - 2033 (Revenue in USD Million and Procedure Volume in Thousand Units)
  • Fig. 49 Key Country Dynamics
  • Fig. 50 Canada Covered Stent Market Estimates and Forecasts, 2021 - 2033 (Revenue in USD Million and Procedure Volume in Thousand Units)
  • Fig. 51 Key Country Dynamics
  • Fig. 52 Mexico Covered Stent Market Estimates and Forecasts, 2021 - 2033 (Revenue in USD Million and Procedure Volume in Thousand Units)
  • Fig. 53 Europe Covered Stent Market Estimates and Forecasts, 2021 - 2033 (Revenue in USD Million and Procedure Volume in Thousand Units)
  • Fig. 54 Key Country Dynamics
  • Fig. 55 UK Covered Stent Market Estimates and Forecasts, 2021 - 2033 (Revenue in USD Million and Procedure Volume in Thousand Units)
  • Fig. 56 Key Country Dynamics
  • Fig. 57 Germany Covered Stent Market Estimates and Forecasts, 2021 - 2033 (Revenue in USD Million and Procedure Volume in Thousand Units)
  • Fig. 58 Key Country Dynamics
  • Fig. 59 Spain Covered Stent Market Estimates and Forecasts, 2021 - 2033 (Revenue in USD Million and Procedure Volume in Thousand Units)
  • Fig. 60 Key Country Dynamics
  • Fig. 61 France Covered Stent Market Estimates and Forecasts, 2021 - 2033 (Revenue in USD Million and Procedure Volume in Thousand Units)
  • Fig. 62 Key Country Dynamics
  • Fig. 63 Italy Covered Stent Market Estimates and Forecasts, 2021 - 2033 (Revenue in USD Million and Procedure Volume in Thousand Units)
  • Fig. 64 Key Country Dynamics
  • Fig. 65 Norway Covered Stent Market Estimates and Forecasts, 2021 - 2033 (Revenue in USD Million and Procedure Volume in Thousand Units)
  • Fig. 66 Key Country Dynamics
  • Fig. 67 Denmark Covered Stent Market Estimates and Forecasts, 2021 - (Revenue in USD Million and Procedure Volume in Thousand Units)
  • Fig. 68 Key Country Dynamics
  • Fig. 69 Sweden Covered Stent Market Estimates and Forecasts, 2021 - 2033 (Revenue in USD Million and Procedure Volume in Thousand Units)
  • Fig. 70 Asia Pacific Covered Stent Market Estimates and Forecasts, 2021 - 2033 (Revenue in USD Million and Procedure Volume in Thousand Units)
  • Fig. 71 Key Country Dynamics
  • Fig. 72 Japan Covered Stent Market Estimates and Forecasts, 2021 - 2033 (Revenue in USD Million and Procedure Volume in Thousand Units)
  • Fig. 73 Key Country Dynamics
  • Fig. 74 China Covered Stent Market Estimates and Forecasts, 2021 - 2033 (Revenue in USD Million and Procedure Volume in Thousand Units)
  • Fig. 75 Key Country Dynamics
  • Fig. 76 India Covered Stent Market Estimates and Forecasts, 2021 - 2033 (Revenue in USD Million and Procedure Volume in Thousand Units)
  • Fig. 77 Key Country Dynamics
  • Fig. 78 Australia Covered Stent Market Estimates and Forecasts, 2021 - 2033 (Revenue in USD Million and Procedure Volume in Thousand Units)
  • Fig. 79 Key Country Dynamics
  • Fig. 80 South Korea Covered Stent Market Estimates and Forecasts, 2021 - 2033 (Revenue in USD Million and Procedure Volume in Thousand Units)
  • Fig. 81 Key Country Dynamics
  • Fig. 82 Thailand Covered Stent Market Estimates and Forecasts, 2021 - 2033 (Revenue in USD Million and Procedure Volume in Thousand Units)
  • Fig. 83 Latin America Covered Stent Market Estimates and Forecasts, 2021 - 2033 (Revenue in USD Million and Procedure Volume in Thousand Units)
  • Fig. 84 Key Country Dynamics
  • Fig. 85 Brazil Covered Stent Market Estimates and Forecasts, 2021 - 2033 (Revenue in USD Million and Procedure Volume in Thousand Units)
  • Fig. 86 Key Country Dynamics
  • Fig. 87 Argentina Covered Stent Market Estimates and Forecasts, 2021 - 2033 (Revenue in USD Million and Procedure Volume in Thousand Units)
  • Fig. 88 MEA Covered Stent Market Estimates and Forecasts, 2021 - 2033 (Revenue in USD Million and Procedure Volume in Thousand Units)
  • Fig. 89 Key Country Dynamics
  • Fig. 90 South Africa Covered Stent Market Estimates and Forecasts, 2021 - 2033 (Revenue in USD Million and Procedure Volume in Thousand Units)
  • Fig. 91 Key Country Dynamics
  • Fig. 92 Saudi Arabia Covered Stent Market Estimates and Forecasts, 2021 - 2033 (Revenue in USD Million and Procedure Volume in Thousand Units)
  • Fig. 93 Key Country Dynamics
  • Fig. 94 UAE Covered Stent Market Estimates and Forecasts, 2021 - 2033 (Revenue in USD Million and Procedure Volume in Thousand Units)
  • Fig. 95 Key Country Dynamics
  • Fig. 96 Kuwait Covered Stent Market Estimates and Forecasts, 2021 - 2033 (Revenue in USD Million and Procedure Volume in Thousand Units)
  • Fig. 97 Key company categorization
  • Fig. 98 Heat map analysis 2025